30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

THOMAS PAUL

Track

Insider profile

Performance

Overall performance
1.3
Performance over holding periods
1.3
30 days 90 days 120 days
Average return -13% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
THOMAS PAUL's trades of AxoGen Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-10 2025-12-09
US AxoGen Inc (AXGN)
S Sale
90,636 +23.2%
209.65
US$362,400 		90,636 +23.2% 209.65 US$362,400
2025-12-09 2025-12-09
US AxoGen Inc (AXGN)
PrS Proposed sale
68,165
314.47
US$2,214,960 		68,165 314.47 US$2,214,960
2022-11-03 2022-11-01
US ABIOMED Inc (ABMD)
PlS Planned sale
92,515 +22.3%
190.19
US$836,370 		92,515 +22.3% 190.19 US$836,370
2020-08-11 2020-08-10
US ABIOMED Inc (ABMD)
PlS Planned sale
2,000 -23.4%
303.41
US$606,820 		2,000 -23.4% 303.41 US$606,820
2020-03-04 2020-03-02
US ABIOMED Inc (ABMD)
PlS Planned sale
2,000 -18.3%
151.78
US$303,561 		2,000 -18.3% 151.78 US$303,561
2020-02-12 2020-02-10
US ABIOMED Inc (ABMD)
PlS Planned sale
2,000 -15.5%
181.13
US$362,250 		2,000 -15.5% 181.13 US$362,250